Theranostic programs are expanding rapidly, creating a growing need to understand how institutions implement ...

From the early use of radioiodine to the expanding reach of prostate-specific membrane antigen and somatostatin receptor ...

Technologists are increasingly responsible for complex theranostic procedures, yet formal training and standardized protocols ...

Reexamining Compliance with Gastric Emptying Scintigraphy Guidelines: An Updated Analysis of the Intersocietal Accreditation Commission Database Gastric Emptying Scintigraphy 2024: Still A Need for ...

You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...

You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...

Radioligand therapy (RLT) is a recent term for long established nuclear medicine practices. Although radioiodine provides the historical foundations of theranostics, the prototype RLTs include ...

Theranostics is changing how we approach treatment in nuclear medicine. Combining targeted imaging with radiopharmaceutical therapy allows us to personalize care in ways that were not previously ...

The widespread success of 177Lu-PSMA-617 for prostate cancer has generated unprecedented volume in theranostics. Prostate-specific membrane antigen–targeted theranostics is possibly the most complex ...

The rapid expansion of radiopharmaceutical therapy, fueled by new radiopharmaceuticals approved by the Food and Drug Administration and novel theranostic approaches, has created an urgent demand for ...

The integration of targeted therapies and diagnostic imaging has significantly advanced the field of nuclear medicine. This article highlights the critical importance of comprehensive training and ...